Searched for
LANXESS AG
Iran price shock set to hit products from cleaning to tiresConsumers face rising costs for cleaning supplies, tires, and animal feed. European chemical firms like BASF and Lanxess are increasing pri...- Godavari Biorefineries IPO subscribed 78% on Day 3 so far, GMP drops to 4%. Check detailsThe IPO comprises a fresh issue of Rs 325 crore and an OFS of up to 6.53 million shares by existing shareholders and promoters. Mandala Cap...
- Godavari Biorefineries IPO subscribed 37% on Day 2 so far. Check GMP, other detailsGodavari Biorefineries' IPO has seen a tepid response, with only 37% subscription so far. Analysts express caution due to high debt and rec...
- Godavari Biorefineries IPO opens for subscription. Should you bid?Godavari Biorefineries' IPO opens for subscription with a price band of Rs 334-342 per share. The IPO includes a fresh issue of Rs 325 cror...
- Godavari Biorefineries' GMP muted ahead of issue opening on October 23Godavari Biorefineries IPO opens on October 23, priced at Rs 334-352 per share. Grey market premium is Rs 0, indicating a potential flat or...
- Godavari Biorefineries sets IPO price band at Rs 334-352 per shareGodavari Biorefineries sets a price band for its Rs 555-crore IPO at Rs 334-352 per share. The offering comprises a fresh issue worth Rs 32...
- LANXESS India completes expansion of Rhenodiv plant at Jhagadia, GujaratThe company said that the increased capacity of Rhein Chemie business unit will meet the demand of the Indian Sub-continent and the Asian t...
- Race for speedier lithium is underway from Arkansas to ArgentinaThis new way of mining lithium is being seen as the solution for increasing output while protecting the environment all across the world’s ...
- ‘Lehman II’ burns global chemical firms, but Indian players have the balm to protect themselvesGlobal chemical biggies are grappling with an ‘inventory recession’ and Indian players are starting to feel the pinch. But experts say the ...
- It feels like 'Lehman II’ in this crucial industryThe German specialty chemical maker Lanxess AG last week had warned recent fall in sales volumes was more severe than in the 2008-09 recess...
- Germany’s Lanxess lines up Rs 1,250-cr Capex planThe Germany-headquartered company, which set up base in India in 2004, will invest on expanding production capacities for chemical intermed...
- Biocon in talks with Bayer for drug developmentTwo pharma cos may sign pact involving co-development of new biotech drugs & research services.
Load More
